Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | follicle stimulating hormone receptor | Get druggable targets OG5_130089 | All targets in OG5_130089 |
Brugia malayi | follicle stimulating hormone receptor | Get druggable targets OG5_130089 | All targets in OG5_130089 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.0307 | 0.0307 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0693 | 0.6474 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.005 | 0.0307 | 0.1706 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.0061 | 0.0418 | 0.5 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0061 | 0.0418 | 0.0646 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Brugia malayi | MH2 domain containing protein | 0.012 | 0.0985 | 0.1521 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0093 | 0.0727 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.005 | 0.0307 | 0.1706 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.028 | 0.2512 | 0.3879 |
Trypanosoma brucei | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.1123 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.0307 | 0.1706 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 0.9998 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.5 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0093 | 0.0727 | 1 |
Echinococcus multilocularis | geminin | 0.0202 | 0.1771 | 0.2736 |
Trichomonas vaginalis | Sialidase-1 precursor, putative | 0.1061 | 1 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.0307 | 0.0307 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.005 | 0.0307 | 0.1706 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0202 | 0.1771 | 0.2736 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 0.9998 |
Trypanosoma brucei | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.012 | 0.0985 | 0.1521 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.005 | 0.0307 | 0.0475 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.005 | 0.0307 | 0.0475 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.005 | 0.0307 | 0.1706 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.012 | 0.0985 | 0.1521 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0093 | 0.0727 | 0.1123 |
Brugia malayi | MAP kinase sur-1 | 0.005 | 0.0307 | 0.0475 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.005 | 0.0307 | 0.0475 |
Onchocerca volvulus | 4.1 G protein, putative homolog | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.005 | 0.0307 | 0.0475 |
Trypanosoma brucei | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.0307 | 0.0307 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Brugia malayi | follicle stimulating hormone receptor | 0.028 | 0.2512 | 0.3879 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0061 | 0.0418 | 0.0646 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0693 | 0.6474 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0673 | 0.6275 | 0.9693 |
Brugia malayi | Probable ClpP-like protease | 0.0093 | 0.0727 | 0.1123 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.0061 | 0.0418 | 0.5 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0693 | 0.6474 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.0307 | 0.1706 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0673 | 0.6275 | 0.9693 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.5 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 1 |
Trypanosoma brucei | trans-sialidase | 0.0206 | 0.1802 | 1 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0693 | 0.6474 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0202 | 0.1771 | 0.2736 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.0061 | 0.0418 | 0.4744 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0018 | 0 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.005 | 0.0307 | 1 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0093 | 0.0727 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Trypanosoma brucei | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0693 | 0.6474 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0093 | 0.0727 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.005 | 0.0307 | 0.0475 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 0.9998 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.005 | 0.0307 | 0.0475 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Echinococcus granulosus | geminin | 0.0202 | 0.1771 | 0.2736 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.0307 | 0.0307 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.066 | 0.6155 | 0.6155 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.005 | 0.0307 | 1 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.0206 | 0.1802 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0673 | 0.6275 | 0.9693 |
Trypanosoma brucei | trans-sialidase, putative | 0.0206 | 0.1802 | 1 |
Entamoeba histolytica | Pten 3-phosphoinositide phosphatase, putative | 0.0018 | 0 | 0.5 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 0.1123 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.005 | 0.0307 | 0.2853 |
Trypanosoma cruzi | trans-sialidase, putative | 0.0206 | 0.1802 | 0.9998 |
Onchocerca volvulus | 0.0018 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.0727 | 0.1123 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0093 | 0.0727 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.005 | 0.0307 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 1 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-002. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-017. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-001. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-026. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-015. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-021. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: Cell Viability - LYMP2-013. CellTiter-Glo luminescent cell viability assay (Promega), as a homogeneous method to measure the number of viable cells in culture was used. The end point readout of this assay is based on quantitation of intracellular ATP, an indicator of metabolic activity, using the luciferase reaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.